Zacks Investment Research on MSN

MRK stock gains after CHMP backs Keytruda combo for bladder cancer

Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products for ...
Zacks Investment Research on MSN

GILD scores FDA win for HDV drug, CHMP backs Trodelvy

Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults ...